Soru

Zorluk: Çok zorPharmacokinetic and Pharmacodynamic Principles

A clinical pharmacologist is assisting the critical care team with dosing adjustments for patients experiencing severe hemodynamic and metabolic derangements. The relationship between hepatic blood flow (QQ), intrinsic hepatocellular clearance (ClintCl_{int}), and the fraction of unbound drug (fuf_u) mathematically dictates the disposition of hepatically cleared medications. Carefully evaluate the following patient scenarios and drug properties. Pair each specific clinical scenario with its most accurate primary pharmacokinetic consequence.

  • Intravenous administration of a high-extraction ratio drug (e.g., propofol) during acute cardiogenic shockClearance is markedly reduced because elimination is predominantly rate-limited by hepatic blood perfusion.
  • Intravenous administration of a low-extraction ratio drug (e.g., ropivacaine) following long-term therapy with a potent CYP450 enzyme inducerClearance is markedly enhanced because elimination is predominantly rate-limited by the liver's intrinsic metabolic capacity.
  • Intravenous administration of a highly protein-bound, low-extraction ratio drug (e.g., phenytoin) in a patient with nephrotic syndrome and severe hypoalbuminemiaTotal systemic clearance increases, leading to a lower total steady-state concentration, while the pharmacologically active free drug concentration remains unchanged.
  • Oral administration of a high-extraction ratio drug (e.g., propranolol) in a patient with advanced liver cirrhosis and severe portosystemic shuntingSystemic bioavailability is substantially increased because the medication evades first-pass metabolism, leading to a much higher area under the curve (AUC).

Cevap

1 matches with hepatic blood perfusion rate-limitation, 2 matches with intrinsic metabolic capacity enhancement, 3 matches with increased total clearance but unchanged free concentration, and 4 matches with increased systemic bioavailability due to evaded first-pass metabolism.
The matching correctly links physiological derivations of the general hepatic clearance equation to specific clinical perturbations, recognizing that high-extraction drugs are flow-limited (ClH≈QCl_H \approx Q) while low-extraction drugs are capacity- and binding-limited (ClH≈fu×ClintCl_H \approx f_u \times Cl_{int}).

Adım Adım Çözüm

1
Analyze the pharmacokinetic formula for hepatic clearance
ClH=Q×(fu×Clint)/(Q+fu×Clint)Cl_H = Q \times (f_u \times Cl_{int}) / (Q + f_u \times Cl_{int})
This formula fundamentally differentiates how high-extraction and low-extraction drugs respond to physiological changes.
2
Evaluate high-extraction ratio drugs given intravenously
Since fu×Clint≫Qf_u \times Cl_{int} \gg Q, the denominator approximates to fu×Clintf_u \times Cl_{int}, simplifying the equation to ClH≈QCl_H \approx Q. Therefore, cardiogenic shock (decreased QQ) directly reduces clearance.
Identifies the correct match for the propofol/cardiogenic shock scenario.
3
Evaluate low-extraction ratio drugs given intravenously
Since Q≫fu×ClintQ \gg f_u \times Cl_{int}, the denominator approximates to QQ, simplifying the equation to ClH≈fu×ClintCl_H \approx f_u \times Cl_{int}. Therefore, enzyme inducers (increased ClintCl_{int}) directly increase clearance.
Identifies the correct match for the ropivacaine/CYP induction scenario.
4
Analyze the effect of protein binding changes on low-extraction ratio drugs
Hypoalbuminemia increases fuf_u, which increases total ClHCl_H. The total steady-state concentration drops (Css=Dose/CltotalCss = Dose / Cl_{total}). However, the free steady-state concentration (Cssfree=fu×Css=fu×(Dose/(fu×Clint))=Dose/ClintCss_{free} = f_u \times Css = f_u \times (Dose / (f_u \times Cl_{int})) = Dose / Cl_{int}) remains unchanged.
Explains the non-intuitive behavior of highly protein-bound, low-extraction drugs like phenytoin during hypoalbuminemia.
5
Evaluate high-extraction ratio drugs given orally during portosystemic shunting
Shunting causes orally absorbed drug to bypass the liver entirely before entering systemic circulation, massively increasing the area under the curve (AUC) and bioavailability.
Identifies the correct match for the propranolol/cirrhosis scenario.

Anahtar Kavram

Hepatic Clearance Kinetics, Extraction Ratios, and Protein Binding
Bu soruyu puanla